R. Arranz
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 19
- Hematopoietic Stem Cell Transplantation 15
- Acute Myeloid Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 17
- Co-authors
- Adrían AlegreÁ FigueraE. CondéRafael de la CámaraJ M Fernández-RañadaJ. MarínAntonio GutiérrezMarı́a Dolores Caballero
- Journals
- Bone Marrow Transplantation (7 papers)Haematologica (6 papers)Annals of Oncology (2 papers)Annals of Hematology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- SpainUnited KingdomSwitzerland
In The Last Decade
R. Arranz
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 81
- Pathology and Forensic Medicine 717
- Hematology 429
- Oncology 861
- Genetics 264
- Immunology 340
Countries citing papers authored by R. Arranz
This map shows the geographic impact of R. Arranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Arranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Arranz more than expected).
Fields of papers citing papers by R. Arranz
This network shows the impact of papers produced by R. Arranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Arranz. The network helps show where R. Arranz may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Arranz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 192 | |
| 2 | 2013 | 23 | |
| 3 | 2012 | 52 | |
| 4 | 2011 | 140 | |
| 5 | 2010 | 49 | |
| 6 | 2007 | 5 | |
| 7 | 2007 | 89 | |
| 8 | 2007 | 55 | |
| 9 | 2004 | 70 | |
| 10 | 2003 | 5 | |
| 11 | 2003 | 30 | |
| 12 | 2003 | 93 | |
| 13 | 2001 | 59 | |
| 14 | 1999 | 22 | |
| 15 | 1998 | 47 | |
| 16 | 1998 | 24 | |
| 17 | 1997 | 45 | |
| 18 | 1997 | 106 | |
| 19 | 1996 | 75 | |
| 20 | More about omeprazole-cyclosporine interaction. | 1993 | 12 |
About R. Arranz
R. Arranz is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Dermatology and Emergency Medicine, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Hematopoietic Stem Cell Transplantation (15 papers), Viral-associated cancers and disorders (9 papers), Acute Myeloid Leukemia Research (7 papers), Cutaneous lymphoproliferative disorders research (4 papers), Hematological disorders and diagnostics (4 papers), T-cell and Retrovirus Studies (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (717 citations), Hematology (429 citations), Oncology (861 citations), Genetics (264 citations) and Immunology (340 citations). R. Arranz has collaborated with scholars based in Spain, United Kingdom and Switzerland. Frequent co-authors include Adrían Alegre, Á Figuera, E. Condé, Rafael de la Cámara, J M Fernández-Rañada, J. Marín, Antonio Gutiérrez, Marı́a Dolores Caballero, Anna Sureda and Antonio Léon. Their work appears in journals such as Bone Marrow Transplantation, Haematologica, Annals of Oncology, Annals of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.